Hemostatic medicine
5 ampoules of 5 ml

COMPOSITION: Tranexamic acid 500 mg

INDICATIONS FOR APPLICATION:

  • Bleeding or risk of bleeding with increased fibrinolysis, as generalized (bleeding during surgery and in the postoperative period, postpartum haemorrhage, manual separation of the posterior, chorionic abruption, bleeding in pregnancy, malignant neoplasms of the pancreas and the prostate glands, hemophilia, hemorrhagic complications of fibrinolytic therapy, thrombocytopenic purpura, leukemia, liver disease, previous therapy streptokinase), and local (uterine, conization of the cervix for carcinoma, nasal, pulmonary, gastrointestinal bleeding, hematuria, bleeding after prostatectomy, tooth extraction in patients with hemorrhagic diathesis).
  • Operative interventions on the bladder.
  • Surgical manipulations with a systemic inflammatory reaction (sepsis, peritonitis, pancreonecrosis, severe and moderate severity of gestosis, shock of various etiologies and other critical states).

CONTRAINDICATIONS: Hypersensitivity to the drug, subarachnoid hemorrhage. With caution – thrombohemorrhagic complications (in combination with heparin and indirect anticoagulants), thrombosis (deep vein thrombophlebitis, thromboembolic syndrome, myocardial infarction), color vision disorders, hematuria from the upper divisions urinary tract (blood clot obstruction possible), renal failure (cumulation possible).

MODE OF APPLICATION: When generalized fibrinolysis is administered in a single dose of 15 mg / kg every 6-8 hours, injection rate -1 ml / min.